Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 984 entries
View as:

Entyvio (Vedolizumab) Long Term Safety Study

Phase: N/A Priority: Normal
NCT ID: NCT02674308 Org: User:
Start: 03/24/15 End: 07/30/21 Due: 07/30/22

A Study on the Outcomes of Recombinant Von Willebrand Factor on Demand Treatment and Prevention and Treatment of Bleeding During and After Surgery in Adults With Inherited Von Willebrand Disease in the United Kingdom (UK)

Phase: N/A Priority: Normal
NCT ID: NCT06433778 Org: User:
Start: 12/16/21 End: 10/30/23 Due: 10/30/24

Long-term Study of SYR-472

Phase: N/A Priority: Normal
NCT ID: NCT01431807 Org: User:
Start: 09/01/11 End: 06/01/13 Due: 06/01/14

Real-world Usage of HyQvia in Multiple Myeloma Adults With Secondary Immunodeficiency

Phase: N/A Priority: Normal
NCT ID: NCT05879757 Org: User:
Start: 10/17/23 End: 02/16/27 Due: 02/16/28

Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea

Phase: N/A Priority: Normal
NCT ID: NCT00672061 Org: User:
Start: 07/31/03 End: 12/31/03 Due: 12/31/04

A Study of the Quality of Life in Adults With Crohn's Disease With Complex Perianal Fistulas

Phase: N/A Priority: Normal
NCT ID: NCT04876690 Org: User:
Start: 07/09/21 End: 05/27/22 Due: 05/27/23

Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00225264 Org: User:
Start: 10/31/03 End: 05/31/06 Due: 05/31/07

Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.

Phase: N/A Priority: Normal
NCT ID: NCT00708175 Org: User:
Start: 05/31/08 End: 02/28/11 Due: 02/28/12

Phase III Study of MLN0002 (300 mg) in Treatment of Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02038920 Org: User:
Start: 01/28/14 End: 05/21/19 Due: 05/21/20

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of TAK-994 in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT03933488 Org: User:
Start: 05/01/19 End: 03/29/20 Due: 03/29/21

A Study in Children and Adolescents on the Effectiveness of Takeda's Licensed Dengue Vaccine TDV Against Hospitalization Due to Dengue Disease

Phase: N/A Priority: Normal
NCT ID: NCT06843226 Org: User:
Start: 03/05/25 End: 12/31/29 Due: 12/31/30

A Study of Ponatinib With Chemotherapy in Children, Teenagers, and Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT04501614 Org: User:
Start: 02/24/21 End: 07/19/24 Due: 07/19/25

Study to Assess the Effects of Daily Administration of Pioglitazone on Brain Hemodynamics in Healthy Elderly Participants

Phase: N/A Priority: Normal
NCT ID: NCT01456117 Org: User:
Start: 11/30/11 End: 07/31/12 Due: 07/31/13

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

Phase: N/A Priority: Normal
NCT ID: NCT00676260 Org: User:
Start: 12/31/02 End: 08/31/04 Due: 08/31/05

Safety and Efficacy Study of Vortioxetine (Lu AA21004) in Adults With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01179516 Org: User:
Start: 08/31/10 End: 06/30/12 Due: 06/30/13

A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)

Phase: N/A Priority: Normal
NCT ID: NCT05494593 Org: User:
Start: 02/28/23 End: 07/17/28 Due: 07/17/29

Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory Drugs

Phase: N/A Priority: Normal
NCT ID: NCT00787254 Org: User:
Start: 04/30/07 End: 05/31/09 Due: 05/31/10

The Use of Lansoprazole to Treat Infants With Symptoms of Gastroesophageal Reflux

Phase: N/A Priority: Normal
NCT ID: NCT00324974 Org: User:
Start: 06/30/06 End: 05/31/07 Due: 05/31/08

Efficacy Study of Pioglitazone and Atorvastatin Combination Therapy in Treating Subjects With Elevated Risk for Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT00770575 Org: User:
Start: 06/30/05 End: 10/31/06 Due: 10/31/07

A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06550076 Org: User:
Start: 09/04/24 End: 05/07/26 Due: 05/07/27

Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease

Phase: N/A Priority: Normal
NCT ID: NCT02388971 Org: User:
Start: 04/30/16 End: 04/30/16 Due: 04/30/17

A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)

Phase: N/A Priority: Normal
NCT ID: NCT05543187 Org: User:
Start: 01/10/23 End: 07/31/25 Due: 07/31/26

Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT00286481 Org: User:
Start: 03/31/06 End: 05/31/07 Due: 05/31/08

Efficacy and Safety of Alogliptin Compared to Glipizide in Elderly Diabetics

Phase: N/A Priority: Normal
NCT ID: NCT00707993 Org: User:
Start: 06/30/08 End: 08/31/10 Due: 08/31/11

Efficacy and Safety of Candesartan Cilexetil Plus Hydrochlorothiazide in Subjects With Severe Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01012479 Org: User:
Start: 10/31/09 End: 06/30/10 Due: 06/30/11